News Daily News JACC Statement Focuses on PAD Disparities, Gaps in Care L.A. McKeown December 04, 2023
News Conference News VIVA 2023 ‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion L.A. McKeown November 03, 2023
News Features Chaos and Questions: New Public-Access Policies Put Journals in Flux Michael O'Riordan August 14, 2023
News Daily News CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting L.A. McKeown July 12, 2023
News Daily News FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed L.A. McKeown July 11, 2023
News Conference News ISET 2023 Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine Caitlin E. Cox January 26, 2023
News Conference News ISET 2023 ‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role Caitlin E. Cox January 18, 2023
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential L.A. McKeown December 06, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News VIVA 2022 ‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups L.A. McKeown November 04, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Daily News Risk of Radiation Low for Pregnant Operators When Precautions Taken Michael O'Riordan September 27, 2022
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022